Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISRG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$439.80-2.1%$459.71$417.74▼$603.88$159.03B1.512.26 million shs2.09 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical+1.69%+3.88%-3.56%-10.11%-19.41%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISRGIntuitive Surgical$439.80-2.1%$459.71$417.74▼$603.88$159.03B1.512.26 million shs2.09 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISRGIntuitive Surgical+1.69%+3.88%-3.56%-10.11%-19.41%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISRGIntuitive Surgical 2.67Moderate Buy$579.3331.73% UpsideCurrent Analyst Ratings BreakdownLatest ISRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026ISRGIntuitive Surgical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)5/18/2026ISRGIntuitive Surgical Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$650.00 ➝ $520.004/23/2026ISRGIntuitive Surgical BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$712.00 ➝ $651.004/22/2026ISRGIntuitive Surgical HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$653.00 ➝ $604.004/22/2026ISRGIntuitive Surgical Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$575.00 ➝ $610.004/22/2026ISRGIntuitive Surgical The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$609.00 ➝ $621.004/22/2026ISRGIntuitive Surgical Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$560.00 ➝ $515.004/22/2026ISRGIntuitive Surgical Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$615.00 ➝ $577.004/22/2026ISRGIntuitive Surgical Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$622.00 ➝ $573.004/22/2026ISRGIntuitive Surgical JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$625.00 ➝ $550.00(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISRGIntuitive Surgical$10.06B15.48$9.09 per share48.40$49.69 per share8.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISRGIntuitive Surgical$2.86B$8.2553.3144.833.5828.15%15.98%14.07%7/28/2026 (Estimated)Latest ISRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/21/2026Q1 2026ISRGIntuitive Surgical$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthISRGIntuitive SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISRGIntuitive SurgicalN/A4.613.59Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISRGIntuitive Surgical83.64%Insider OwnershipCompanyInsider OwnershipISRGIntuitive Surgical0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISRGIntuitive Surgical17,021354.16 million352.04 millionOptionableISRG HeadlinesRecent News About These Companies2 Healthcare Stocks Worth Investigating and 1 Facing Headwinds35 minutes ago | finance.yahoo.com3 Medical Instrument Stocks Exploring GenAI to Tackle Industry WoesMay 21 at 2:35 PM | zacks.comQuantum Computing and Robotics Are Arriving Faster Than Most Investors Realize and After Years of Covering This Space These 3 ETFs Stand OutMay 21 at 1:31 PM | 247wallst.comWhy Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report?May 21 at 12:31 PM | zacks.comISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver?May 21 at 12:17 PM | finance.yahoo.comIntuitive Announces Innovations to Advance Quintuple AimMay 21 at 12:17 PM | finance.yahoo.com2 Most Compelling Stocks to Buy for Long‑Term Investors Right NowMay 21 at 12:17 PM | fool.comISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver?May 21 at 9:56 AM | zacks.comIntuitive Announces Innovations to Advance Quintuple AimMay 21 at 9:15 AM | globenewswire.comGlobal Retirement Partners LLC Boosts Position in Intuitive Surgical, Inc. $ISRGMay 21 at 7:59 AM | marketbeat.comVerde Servicos Internacionais S.A. Sells 17,258 Shares of Intuitive Surgical, Inc. $ISRGMay 21 at 7:10 AM | marketbeat.comLeonteq Securities AG Makes New Investment in Intuitive Surgical, Inc. $ISRGMay 21 at 6:25 AM | marketbeat.comRathbones Group PLC Sells 16,919 Shares of Intuitive Surgical, Inc. $ISRGMay 21 at 6:08 AM | marketbeat.comIntuitive Surgical, Inc. $ISRG Shares Acquired by PNC Financial Services Group Inc.May 21 at 5:33 AM | marketbeat.comIntuitive Surgical, Inc. $ISRG Stock Position Lifted by ABN Amro Investment SolutionsMay 21 at 3:18 AM | marketbeat.comJim Cramer on Globus Medical: “There Is Not a Lot of Money to Be Made in This One”May 20 at 6:03 PM | finance.yahoo.com3 big reasons ISRG should be on your watchlistMay 20 at 8:02 AM | msn.comNorthbridge Financial Group LLC Takes Position in Intuitive Surgical, Inc. $ISRGMay 20 at 5:50 AM | marketbeat.comJag Capital Management LLC Takes $18.77 Million Position in Intuitive Surgical, Inc. $ISRGMay 20 at 5:42 AM | marketbeat.comSaranac Partners Ltd Grows Position in Intuitive Surgical, Inc. $ISRGMay 20 at 5:33 AM | marketbeat.comHighTower Advisors LLC Has $113.53 Million Stock Holdings in Intuitive Surgical, Inc. $ISRGMay 20 at 5:15 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026AMD’s Breakout Isn’t the Story—This Catalyst IsBy Thomas Hughes | April 24, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 20263 Energy Stocks to Buy and 2 to Avoid as AI Power Demand ExplodesBy Bridget Bennett | May 4, 2026Intuitive Surgical's Selloff Sets Up a 30% Rebound OpportunityBy Thomas Hughes | April 23, 2026ISRG Company DescriptionsIntuitive Surgical NASDAQ:ISRG$439.80 -9.23 (-2.06%) Closing price 04:00 PM EasternExtended Trading$440.70 +0.90 (+0.20%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
